BLM and Bloom syndrome: More importantly, we found that BLM activated NRF2/HO-1 signaling, and NRF2 inhibitor ML385 significantly abolished the influences of BLM on blue light-treated ARPE-19 cells, suggesting that BLM ameliorated optical damage caused by blue light by activating NRF2/HO-1 signaling.